Novo sells semaglutide as Ozempic and Rybelsus for diabetes and as Wegovy for obesity. In price talks, CMS will treat the different forms as a single product.

Wegovy, Ozempic added to list of drugs where the federal government will try winning discounts from manufacturers.

Stock prices for Novo Nordisk fell by about 3% at market open after the Biden administration selected its revolutionary drugs ...

Ozempic was one of the 15 drugs selected for the 2027 Medicare drug price negotiation program three days before ...

The findings were published in the journal Environmental Research. Researchers from ...

Instead of using the controversial body mass index, or BMI, to assess weight, an international group of scientists proposes ...

The U.S. government on Friday announced a list of 15 prescription medicines targeted for Medicare price negotiations for 2027 ...

The Biden administration says popular weight loss drugs like Ozempic and Wegovy have been added to Medicare’s list of ...

Body Mass Index (BMI) has limitations as it doesn't distinguish between muscle and fat, leading to misclassification of ...

People often let chronic conditions such as high blood pressure and diabetes go for a long time without treatment. Here’s why you should address them before symptoms begin.

New Activin R-based medications can emerge as perfect solutions for balancing weight loss and muscle building, making a ...